FIA
NVRO

FNY Investment Advisers’s NEVRO CORP. NVRO Stock Holding History

FNY Investment Advisers’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,000
Closed -$1.25M – 934
2020
Q3 		$1.25M Buy
9,000
+3,500
+64% +$468K 0.53% 52
2020
Q2 		$657K Buy
+5,500
New +$652K 0.38% 67

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FNY Investment Advisers's NVRO Position: Q4 2020 in Review

FNY Investment Advisers sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 9,000 shares — an estimated $1.25M sold.

FNY Investment Advisers first reported a position in NVRO in Q2 2020 and held it in 2 quarters. The position peaked at $1.25M in Q3 2020. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • FNY Investment Advisers reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 9,000 NEVRO CORP. shares in Q4 2020, an estimated $1.25M.
  • FNY Investment Advisers first reported a position in NEVRO CORP. in Q2 2020 and held it in 2 quarters.
  • FNY Investment Advisers's NEVRO CORP. position peaked at $1.25M in Q3 2020.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on FNY Investment Advisers's 13F filing for Q4 2020, filed 19 Jan 2021.